Jonathan Young, Chief Operating Officer at Akero Therapeutics, Inc. (AKRO), sold 5,414 shares at $24.00 ($130K) on 2023-12-27, disclosed to the SEC on 2023-12-29.
Open-market sale of $130k AKRO by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AKRO | SELL | 2025-09-04 | $705K | — | Filing → |
| AKRO | SELL | 2025-08-13 | $1.2M | — | Filing → |
| AKRO | SELL | 2025-06-20 | $159K | — | Filing → |